Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Carcinoma, Renal Cell × olaparib × Clear all

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 15 Ovarian Neoplasms 13 Fallopian Tube Neoplasms 8 Triple Negative Breast Neoplasms 7 Pancreatic Neoplasms 7 Neoplasms 7 Neoplasm Metastasis 6 Prostatic Neoplasms 5 Endometrial Neoplasms 4 Neuroendocrine Tumors 3 Carcinoma, Ovarian Epithelial 3 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Glioma 2 Glioblastoma 2 Cholangiocarcinoma 2 Advanced Solid Tumor 2 Uveal Melanoma 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Solid Tumors 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 SCLC,Extensive Stage 1 Recurrent Ovarian High Grade Serous Adenocarcinoma 1 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Diseases 1 Platinum-sensitive Ovarian Cancer 1

Interventions

Nivolumab 26 pembrolizumab 24 cabozantinib 21 Ipilimumab 16 Magnetic Resonance Spectroscopy 14 Specimen Handling 12 Axitinib 11 Radiosurgery 8 lenvatinib 7 CTLA-4 Antigen 6 Biopsy 6 cemiplimab 5 belzutifan 5 atezolizumab 5 Bevacizumab 5 Standard of Care 4 Radiotherapy 4 Blood Specimen Collection 4 toripalimab 3 avelumab 3 aldesleukin 3 Sunitinib 3 Paclitaxel 3 Everolimus 3 trastuzumab deruxtecan 2 tivozanib 2 pazopanib 2 enfortumab vedotin 2 X-Rays 2 Practice Guidelines as Topic 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03786796 2025-03-13

ORCHID

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡